Day: June 9, 2022

Worldline’s 2022 Annual General Meeting Approval of all resolutions submitted by the board of directors Paris La Défense, June 9, 2022 – Worldline [Euronext: WLN] , leader in the payments industry held today its Annual General Meeting chaired by Mr Bernard Bourigeaud, Chairman of the Board of Directors. The General Shareholders Meeting was held physically and gathered a large quorum of 80.67%. It was broadcast live and is available for replay on the Company’s website. All resolutions have been approved. The General Meeting approved, in particular, the Company and consolidated accounts for the financial year ending December 31st, 2021, as well as the related-parties agreement submitted to its approval. It also ratified the transfer of the Company’s registered office. The General Meeting approved the renewal of Director’s...

Stemtech Corporation Ana GroenewoldMIRAMAR, FL, June 09, 2022 (GLOBE NEWSWIRE) — Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of ADVANCELLS stem cell nutrition, announced today that Ana Groenewold, an Independent Business Partner from Mexico, has attained the high rank of Chairman’s Club Director in May. This coincided with the GLD RSH 90-Day Promotion period where sales and recruitment reached a record 2022 May. “Ana is a very dedicated and determined person who set her sights on becoming a Chairman’s Club Director and excitedly attained this high rank in May” says John W. Meyer, President & COO of Stemtech Corporation. “Stemtech is proud of Ana’s accomplishments and applauds her efforts to share the benefits of our great products and business opportunity”...

EPH European Property Holdings PLC (the ‘Company’) announces the results of the Annual General Meeting held on 09 June 2022 at 11:00 AM at Hotel Amathus, 75 Amathus Avenue, 4532 Limassol, Cyprus ______________________________________________________________________________________________ 9 June 2022, Nicosia, Cyprus / Ad hoc announcement pursuant to Art. 53 LR EPH European Property Holdings PLC held its Annual General Meeting (‘AGM’) on 9 June 2022. All matters contained in the Notice of the AGM issued on 18 May 2022 were considered and accordingly, resolutions were duly approved on the following: 1. Approval of the results of the Company for the year ended on 31 December 2021 2. Acknowledgement of the recommendation of the Board of Directors of the Company not to declare a dividend out of available profits from the year ended on 31...

SIERRA BLANCA, TX, June 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Texas Mineral Resources Corp. (OTCQB: TMRC) an exploration company currently targeting the heavy rare earths, technology metals and a variety of industrial minerals primarily through its 20% ownership interest in the Round Top Mountain project in Texas, is pleased to report that its joint venture partner USA Rare Earth Inc.  today announced its procurement and development of the first fully integrated U.S.-based rare earth metal and sintered neo-magnet manufacturing facility, located in Stillwater, Oklahoma. USA Rare Earth plans to invest more than $100 million in developing the manufacturing facility and will utilize its owned facilities and technology to convert rare earth oxides into metals, magnets and other specialty materials. These products have numerous...

Exhibit I – 6-Month Reduction in Microglial PET Signal from First SPMS Patient(3) Exhibit I – 6-Month Reduction in Microglial PET Signal from First SPMS Patient(3)Exhibit II – Tiziana Pipeline(4) Exhibit II – Tiziana Pipeline(4)Zacks Small-Cap Research Note By John D. Vandermosten, CFA NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences PLC (NASDAQ: TLSA) announced positive clinical results for its second secondary progressive multiple sclerosis (SMPM) patient in a June 8th press release. The ~40 year old individual that was enrolled as the second patient in the trial exhibited clinical improvements on several measures, including positron emission tomography (PET) analysis, neurologic exam and the timed 25-foot walk test after three months of treatment. The results from the second patient are consistent...

FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 AGM STATEMENT The Board of Foresight Enterprise VCT plc is pleased to announce that at the Annual General Meeting of the Company held on 9 June 2022 all of the resolutions were duly passed. The poll voting was as follows:Resolution Votes For Votes Against1 – To Receive the Report and Accounts 11,001,919 (99.46%) 59,290 (0.54%)2 – Approval of the Directors’ Remuneration Report 9,516,979 (87.91%) 1,309,139 (12.09%)3 – Approval of the Directors’ Remuneration Policy 9,417,198 (87.12%) 1,391,666 (12.88%)4 – To re-elect Raymond Abbott as Director 9,784,273 (89.93%) 1,096,047 (10.07%)5 – To re-elect Gaynor Coley as Director 10,595,932 (97.36%) 287,429 (2.64%)6 – To re-elect Michael Gray as Director 9,660,886 (89.19%) 1,171,009...

June 9, 2022 Conditions of availability of information preparedin connection with the Combined Shareholders’ Meetingto be held June 30, 2022 Shareholders are invited to participate to the Combined Shareholders’ Meeting to be held on: Thursday, June 30, 2022 at 2 p.m.,Espace Saint-Martin – 199 bis rue Saint-Martin – 75003 Paris (France) The Preliminary Notice of Meeting, including agenda and proposed resolutions was published in the French Bulletin des annonces légales obligatoires (BALO) on May 25, 2022 and a Notice of Meeting will be published in the journal of legal notices “Affiches Parisiennes” on June 15, 2022. The documents referred to in Article R. 225-83 of the French Commercial Code are made available to shareholders as of this date, in accordance with applicable regulations:any shareholder holding registered shares may request...

ChartWater’s AdEdge Center of Excellence and Calgon Carbon signed an agreement to partner in offering drinking water treatment systems to under-resourced, rural communities. Pittsburgh, Pennsylvania, June 09, 2022 (GLOBE NEWSWIRE) — ChartWater™ a division of Chart Industries, Inc. (“Chart”) (NYSE: GTLS), and Calgon Carbon Corporation (“Calgon Carbon”), a wholly owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) (“Kuraray”), today formally announced an agreement signed in 2021 to jointly offer drinking water systems, using granular activated carbon, to under-resourced rural areas. The terms of the Agreement allow Calgon Carbon to refer all communities in the United States requiring treatment of up to approximately 175 gallons per minute to ChartWater’s AdEdge Water Technologies (AdEdge ), who will source all related GAC from Calgon...

Management Presentation to Be Webcast Live at 1:00 Pm EDT on June 15, 2022 PRINCETON JUNCTION, N.J., June 09, 2022 (GLOBE NEWSWIRE) — MISTRAS Group, Inc. (MG: NYSE) – a leading “one source” multinational provider of technology-enabled asset protection solutions used to maximize the uptime and safety of critical energy, industrial, and public infrastructure – announced today that Dennis Bertolotti, Chief Executive Officer and Edward Prajzner, Chief Financial Officer, will be presenting at the Sidoti Summer Small Cap Virtual Conference, being held from June 15-16, 2022. Management will also be available for one-on-one meetings throughout the conference. The presentation will include information on MISTRAS’ newly-released solutions, including OneSuite™ — the first-ever asset protection software ecosystem — and Sensoria™, the innovative...

Tiziana Life Sciences welcomes positive results from second patient in Foralumab MS studyNEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug administration, today announces an interview with Chief Executive Officer and Chief Scientific Officer Kunwar Shailubhai, PhD and Proactive Investors discussing the positive clinical results from the second patient with Secondary Progressive Multiple Sclerosis (SPMS) in the ongoing study as part of an expanded access program at the Brigham and Women’s Hospital (BWH), Boston, MA. About Foralumab Foralumab (formerly NI-0401), the only entirely human anti-CD3 mAb, shows reduced release of cytokines after IV...